{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T22:42:27Z","timestamp":1765492947909,"version":"3.48.0"},"reference-count":27,"publisher":"BMJ","issue":"6742","license":[{"start":{"date-parts":[[1990,7,7]],"date-time":"1990-07-07T00:00:00Z","timestamp":647308800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[1990,7,7]]},"abstract":"<jats:p>OBJECTIVE--To determine the frequency of an abnormal bleeding time in patients with cirrhosis and to relate this to known factors that affect primary haemostasis and to the severity of liver disease. DESIGN--Prospective clinical and laboratory study in patients admitted for complications or investigations of liver disease. SETTING--Royal Free Hospital hepatobiliary and liver transplantation unit. SUBJECTS--100 Consecutive inpatients aged 17-74 with various forms of cirrhosis, including alcoholic, biliary, autoimmune, viral, and cryptogenic. At least 10 days had elapsed since any episodes of bleeding, resolution of sepsis, or alcohol intake. No patient was taking any drug known to affect primary haemostasis. MAIN OUTCOME MEASURES--Bleeding time as measured with the Simplate double blade template device. A bleeding time longer than 10 minutes was considered abnormal. Other measures were platelet count, prothrombin time, partial thromboplastin time, packed cell volume, and blood urea, serum bilirubin, and serum albumin concentrations, all measured on each subject at the same time by standard laboratory methods. RESULTS--A weak but significant correlation existed between the bleeding time and the platelet count (rs = 0.483; p less than 0.001). There were significantly lower platelet counts, longer prothrombin times, and higher blood urea and serum bilirubin concentrations in the 42 patients with bleeding times of 10 minutes or more compared with the 58 patients with bleeding times less than 10 minutes. Multiple linear regression analysis showed that the bilirubin concentration as well as the platelet count was independently correlated with the bleeding time. The combination of a platelet count greater than 80 x 10(9)\/l and a prothrombin time less than 17 seconds (usually taken as safe limits for performing routine liver biopsy) did not predict a normal bleeding time. Ten of 39 patients fulfilling these criteria had a prolonged bleeding time. CONCLUSIONS--Prolonged bleeding time is common in patients with cirrhosis, even in those with prothrombin times and platelet counts within \"safe limits\" for invasive procedures. The severity of liver disease as assessed by the bilirubin concentration plays an important part in determining the bleeding time in cirrhosis. The bleeding time should be measured when assessing patients for invasive procedures who have a raised bilirubin concentration or poor hepatic function, even if the platelet count and prothrombin time are considered adequate.<\/jats:p>","DOI":"10.1136\/bmj.301.6742.12","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T15:19:55Z","timestamp":1238685595000},"page":"12-15","source":"Crossref","is-referenced-by-count":55,"title":["Bleeding time in patients with hepatic cirrhosis."],"prefix":"10.1136","volume":"301","author":[{"given":"J C","family":"Blake","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Sprengers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Grech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P A","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A K","family":"Burroughs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1990,7,7]]},"reference":[{"key":"ref_1","first-page":"91","article-title":"What about the bleeding time?","volume":"291","author":"Hamblin, T.J.","year":"1985","unstructured":"Hamblin TJ.What about the bleeding time? BrMedJ 1985;291:91.","journal-title":"BrMedJ"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1056\/NEJM197506192922508","article-title":"Platelet function tests: predictive values","volume":"292","author":"Levine, P.H.","year":"1975","unstructured":"Levine PH. Platelet function tests: predictive values. N EnglJ7 Med 1975;292: 1346-7.","journal-title":"N EnglJ7 Med"},{"key":"ref_3","first-page":"369","article-title":"The bleeding time: current practice in the UK","volume":"6","author":"Poller, L.; hompson JM, I.; Tomenson, J.A.","year":"1984","unstructured":"Poller L, I hompson JM, Tomenson JA. The bleeding time: current practice in the UK. Clin Lab Haematol 1984;6:369-73.","journal-title":"Clin Lab Haematol"},{"key":"ref_4","first-page":"107","article-title":"Bleeding time in uremia: a useful test to assess clinical bleeding. American_7ournal of","volume":"7","author":"Steiner, R.W.; Coggins, C.; Carvalho, A.C.A.","year":"1979","unstructured":"Steiner RW, Coggins C, Carvalho ACA. Bleeding time in uremia: a useful test to assess clinical bleeding. American_7ournal of Hepatology 1979;7:107-17.","journal-title":"Hepatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1056\/NEJM197207272870401","article-title":"The bleeding time as a screening test for evaluation of platelet function","volume":"287","author":"Harker, L.A.; Slichter, S.J.","year":"1972","unstructured":"Harker LA, Slichter SJ. The bleeding time as a screening test for evaluation of platelet function. N EnglJ Med 1972;287:155-7.","journal-title":"N EnglJ Med"},{"key":"ref_6","first-page":"187","article-title":"Disordered hemostasis in hepatic disease","volume-title":"ofthe liver","author":"Ratnoff, O.D.","year":"1987","unstructured":"Ratnoff OD. Disordered hemostasis in hepatic disease. In: Schiff L, Schiff ER, eds. Diseases ofthe liver. 6th ed. Philadelphia: Lippincott, 1987:187-207.","edition":"6th ed"},{"key":"ref_7","article-title":"Diseases of the liver and biliary system","author":"Sherlock, S.","year":"1989","unstructured":"Sherlock S. Diseases of the liver and biliary system. 8th ed. Oxford: Blackwell Scientific, 1989.","edition":"8th ed"},{"key":"ref_8","first-page":"189","article-title":"Haematological disorders in liver disease","volume-title":"biliary disease","author":"Chisholm, M.","year":"1985","unstructured":"Chisholm M. Haematological disorders in liver disease. In: Wright R, Millward-Sadler GH, Alberti KGMM, Karran S, eds. Liver and biliary disease. 2nd ed. London: Bailliere Tindall, W B Saunders Co, 1985:189-214.","edition":"2nd ed"},{"key":"ref_9","first-page":"861","article-title":"Hemostatic abnormalities in liver disease","volume-title":"thrombosis: basic principles and clinical practice","author":"Joist, J.H.","year":"1987","unstructured":"Joist JH. Hemostatic abnormalities in liver disease. In: Colman RW, Hirsh J, Marder Vj, Salzman EW, eds. Hetmostasis and thrombosis: basic principles and clinical practice. 2nd ed. Philadelphia: Lippincott, 1987:861-72.","edition":"2nd ed"},{"key":"ref_10","first-page":"217","article-title":"Kinetic and functional studies of platelets. fibrinogen, and plasminogen in patients with hepatic cirrhosis","volume":"99","author":"Stein, S.F.; Harker, L.A.","year":"1982","unstructured":"Stein SF, Harker LA. Kinetic and functional studies of platelets. fibrinogen, and plasminogen in patients with hepatic cirrhosis. 7 Lab Clin Med 1982;99:217-30.","journal-title":"7 Lab Clin Med"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1001\/archinte.1976.03630030050009","article-title":"Platelet aggregation in portal cirrhosis","volume":"136","author":"Ballard, H.S.; Marcus, A.J.","year":"1976","unstructured":"Ballard HS, Marcus AJ. Platelet aggregation in portal cirrhosis. Arch Intern Med 1976;136:316-9.","journal-title":"Arch Intern Med"},{"issue":"1","key":"ref_12","first-page":"1","article-title":"Coagulation studies in liver disease. 7hrombosis et Diathesis Haemorrhagica","volume":"1","author":"Hallen, A.; Nilsson, I.M.","year":"1964","unstructured":"Hallen A, Nilsson IM. Coagulation studies in liver disease. 7hrombosis et Diathesis Haemorrhagica 1964; 1 1:5 1-63."},{"key":"ref_13","first-page":"1174","article-title":"Liver biopsy-indications and procedure","volume":"2","author":"Burroughs, A.K.; Scheuer, P.J.","year":"1986","unstructured":"Burroughs AK, Scheuer PJ. Liver biopsy-indications and procedure. Medicine International 1986;2:1174-6.","journal-title":"Medicine International"},{"key":"ref_14","first-page":"165","article-title":"Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies.]","volume":"2","author":"Picinino, F.; Sagnelli, E.; Pasquale, G.; Giusty, G.","year":"1986","unstructured":"Picinino F, Sagnelli E, Pasquale G, Giusty G. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies.] Hepatol 1986;2:165-73."},{"key":"ref_15","first-page":"254","article-title":"Erfhrungen bei nahezu 20,000 leberblindpunktionen","volume":"76","author":"Wildhirt, E.; Moller, E.","year":"1981","unstructured":"Wildhirt E, Moller E. Erfhrungen bei nahezu 20,000 leberblindpunktionen. Med Klin 1981;76:254-6.","journal-title":"Med Klin"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/BF01313579","article-title":"Bleeding after liver biopsy does not correlate with indices of peripheral coagulation","volume":"26","author":"Ewe, K.","year":"1981","unstructured":"Ewe K. Bleeding after liver biopsy does not correlate with indices of peripheral coagulation. Dig Dis Sci 1981;26:388-93.","journal-title":"Dig Dis Sci"},{"issue":"2","key":"ref_17","first-page":"10","article-title":"Measurement of the bleeding time. International committee communications","volume":"52","author":"Mielke, C.H.","year":"1984","unstructured":"Mielke CH. Measurement of the bleeding time. International committee communications. Thromb Haemost 1984;52:2 10-1.","journal-title":"Thromb Haemost"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF01308429","article-title":"Platelet function in chronic liver disease: relationship to disease severity","volume":"24","author":"Rubin, M.H.; Weston, M.J.; Langley, P.J.; White, Y.; Williams, R.","year":"1979","unstructured":"Rubin MH, Weston MJ, Langley PJ, White Y, Williams R. Platelet function in chronic liver disease: relationship to disease severity. Dig Dis Sci 1979;24:197-202.","journal-title":"Dig Dis Sci"},{"key":"ref_19","series-title":"Gut","first-page":"1495","article-title":"Thrombocvtopenia in liver disease: an immune phenomenon?","volume":"30","author":"Abstract","year":"1990","unstructured":"De Noronha R, Taylor B, Greases M, Triger DR. Thrombocvtopenia in liver disease: an immune phenomenon? [Abstract]. Gut 1990;30:A1495."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0022-2275(20)34955-5","article-title":"I'latelet lipid composition and platelet aggregation in human liver disease","volume":"22","author":"Owen, J.S.; Hutton, R.A.; D)ay, R.C.; Bruckdorfer, R.; McIntyre, N.","year":"1981","unstructured":"Owen JS, Hutton RA, D)ay RC, Bruckdorfer R, McIntyre N. I'latelet lipid composition and platelet aggregation in human liver disease. j Liptd Res 1981;22:423-30.","journal-title":"j Liptd Res"},{"key":"ref_21","first-page":"693","article-title":"Inhibition of platelet aggregation by abnormal high density lipoprotein particles in plasma from patients with hepatic cirrhosis","volume":"i:","author":"Desai, K.; Bagget, C.; Bellamy, M.F.; Mlistry, P.; Burroughs, A.K.; Owen, J.S.","year":"1989","unstructured":"Desai K, Bagget C, Bellamy MF, Mlistry P, Burroughs AK, Owen JS. Inhibition of platelet aggregation by abnormal high density lipoprotein particles in plasma from patients with hepatic cirrhosis. Lancet 1989;i:693-5.","journal-title":"Lancet"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0016-5085(87)90119-3","article-title":"Prospective study of the incidence of ultra-sound detected intrahepatic and subcapular hematomas in patients randomised to 6 or 24 hours of bed rest after perctttaneous liver biopsy","volume":"92","author":"LR, Minttk G.Y.Stttherland; DA, Wiseman; FR, MScDonald; DL, Ding","year":"1987","unstructured":"Minttk GY. Stttherland LR, Wiseman DA, MScDonald FR, Ding DL. Prospective study of the incidence of ultra-sound detected intrahepatic and subcapular hematomas in patients randomised to 6 or 24 hours of bed rest after perctttaneous liver biopsy. Gastroenterologv 1987;92:290-3.","journal-title":"Gastroenterologv"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0140-6736(76)91794-3","article-title":"Correction of abnormal coagulation in chronic liver disease by combined use of fresh frozen plasma and prothrombin complex concentrations","volume":"ii:","author":"Mannucci, P.M.; Franchi, F.; Dioguardi, N.","year":"1976","unstructured":"Mannucci PM, Franchi F, Dioguardi N. Correction of abnormal coagulation in chronic liver disease by combined use of fresh frozen plasma and prothrombin complex concentrations. Lancet 1976;ii:542-5.","journal-title":"Lancet"},{"key":"ref_24","first-page":"1377","article-title":"Desmopressin and bleeding time in patients with cirrhosis","volume":"291","author":"Btirrotighs, A.K.; Mathews, K.; Qadiri, M.","year":"1985","unstructured":"Btirrotighs AK, Mathews K, Qadiri M, et al. Desmopressin and bleeding time in patients with cirrhosis. BrMedJ_ 1985;291:1377-81.","journal-title":"BrMedJ_"},{"key":"ref_25","first-page":"1140","article-title":"Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time","volume":"67","author":"Mannucci, P.M.; Vincente, V.; Vianello, L.","year":"1986","unstructured":"Mannucci PM, Vincente V, Vianello L, et al. Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time. Blood 1986;67:1140-53.","journal-title":"Blood"},{"key":"ref_26","first-page":"365","article-title":"Haemostatic changes in cirrhosis after repeated doses of desamino D arginine vasopressin","volume":"58","author":"Burroughs, A.K.; Taylor, L.; Sprengers, D.; Hutton, R.A.; McIntyre, N.; Kernoff, P.","year":"1987","unstructured":"Burroughs AK, Taylor L, Sprengers D, Hutton RA, McIntyre N, Kernoff P. Haemostatic changes in cirrhosis after repeated doses of desamino D arginine vasopressin [Abstract]. I'hromb Haemost 1987;58:365.","journal-title":"I'hromb Haemost"},{"article-title":"Is bleeding time a useful test in cirrhotic patients?","author":"Abstract","key":"ref_27","unstructured":"Sprengers D, (;rech P, McCormick PA, Mclntyte N, Burroughs AK. Is bleeding time a useful test in cirrhotic patients? [Abstract]. Gut 1987;28: A 1348."}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.301.6742.12","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.301.6742.12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T22:41:25Z","timestamp":1765492885000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.301.6742.12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,7,7]]},"references-count":27,"journal-issue":{"issue":"6742","published-online":{"date-parts":[[1990,7,7]]},"published-print":{"date-parts":[[1990,7,7]]}},"alternative-id":["10.1136\/bmj.301.6742.12"],"URL":"https:\/\/doi.org\/10.1136\/bmj.301.6742.12","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"type":"print","value":"0959-8138"},{"type":"electronic","value":"1468-5833"}],"subject":[],"published":{"date-parts":[[1990,7,7]]}}}